A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Saved in:
| Title: | A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial. |
|---|---|
| Authors: | Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee, USA dspigel@tnonc.com.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Shipley DL; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Waterhouse DM; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Jones SF; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Ward PJ; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Shih KC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hemphill B; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., McCleod M; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Ft. Myers Florida, USA., Whorf RC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Bradenton, Florida, USA., Page RD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Center for Cancer and Blood Disorders, Ft. Worth, Texas, USA., Stilwill J; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Research Medical Center, Kansas City, Missouri, USA., Mekhail T; Florida Hospital Cancer Institute, Orlando, Florida, USA., Jacobs C; Oncogenex, Bothell, Washington, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hainsworth JD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA. |
| Source: | The oncologist [Oncologist] 2019 Dec; Vol. 24 (12), pp. e1409-e1416. Date of Electronic Publication: 2019 Aug 16. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2018-0518 |
